Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 3Not yet recruiting 2Recruiting 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 3Gastrointestinal 3CNS 2Sarcoma 1

Conditions

Brain Neoplasms 2

Interventions

Temozolomide 21Magnetic Resonance Spectroscopy 9Radiotherapy 8Blood Specimen Collection 8Cyclophosphamide 6Bevacizumab 6AZD 6244 6pembrolizumab 5Specimen Handling 4Radiation 4fludarabine 3dinutuximab 3cemiplimab 3aflutinib 3Surgical Procedures, Operative 3Saline Solution 3Radiotherapy, Intensity-Modulated 3Pemetrexed 3Granulocyte-Macrophage Colony-Stimulating Factor 3vorasidenib 2tislelizumab 2osimertinib 2naxitamab 2gallium maltolate 2fludarabine phosphate 2Topotecan 2Standard of Care 2Spinal Puncture 2Receptors, Interleukin-8B 2Radiosurgery 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Indocyanine Green × CNS × Clear all
NCT07254845 2025-11-28

A PROSPECTIVE, SINGLE-CENTERED, ASSESSOR-BLINDED STUDY TO EVALUATE THE CLINICAL EFFICACY OF THE PROPOSED CELL/TISSUE HISTOPATHOLOGY PROCESSOR CCELL (CONFOCAL FLUORESCENCE ENDOMICROSCOPY) FOR INTRAOPERATIVE DIAGNOSIS IN BRAIN TUMORS

VPIX Medical

Phase 1 Not yet recruiting
30 enrolled
CNS

Brain Neoplasms

NCT06867978 2025-03-10

PRECISION

VPIX Medical

Phase 1 Not yet recruiting
100 enrolled
CNS

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡